Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversal of Remimazolam by a Single Dose of Flumazenil After Monitored Anesthesia Care in Gynecological Ambulatory Surgery: a Prospective Randomized Controlled Trial

NCT05382806 is registered in ClinicalTrials.gov with Konkuk University Medical Center as lead sponsor.

NCT NCT05382806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversal of Remimazolam by a Single Dose of Flumazenil After Monitored Anesthesia Care in Gynecological Ambulatory Surgery: a Prospective Randomized Controlled Trial
Lead sponsor
Konkuk University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
August 2, 2022
Completion date
May 13, 2023
Enrollment
224 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ambulatory surgery, flumazenil adverse reaction, postoperative nausea, remimazolam